Lycopene in Treating Patients With Metastatic Prostate Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

January 31, 2004

Primary Completion Date

February 28, 2007

Study Completion Date

October 31, 2009

Conditions
Prostate Cancer
Interventions
DIETARY_SUPPLEMENT

lycopene

Trial Locations (18)

29303

CCOP - Upstate Carolina, Spartanburg

32224

Mayo Clinic - Jacksonville, Jacksonville

45429

CCOP - Dayton, Dayton

55416

CCOP - Metro-Minnesota, Saint Louis Park

55805

CCOP - Duluth, Duluth

55905

Mayo Clinic Cancer Center, Rochester

56303

Coborn Cancer Center, Saint Cloud

57104

CCOP - Sioux Community Cancer Consortium, Sioux Falls

61801

CCOP - Carle Cancer Center, Urbana

70121

CCOP - Ochsner, New Orleans

85259-5404

CCOP - Mayo Clinic Scottsdale Oncology Program, Scottsdale

30342-1701

CCOP - Atlanta Regional, Atlanta

61615-7828

CCOP - Illinois Oncology Research Association, Peoria

52403-1206

CCOP - Cedar Rapids Oncology Project, Cedar Rapids

50309-1016

CCOP - Iowa Oncology Research Association, Des Moines

51101-1733

Siouxland Hematology-Oncology, Sioux City

67214-3882

CCOP - Wichita, Wichita

58501-5505

Medcenter One Health System, Bismarck

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Alliance for Clinical Trials in Oncology

OTHER

NCT00068731 - Lycopene in Treating Patients With Metastatic Prostate Cancer | Biotech Hunter | Biotech Hunter